@Biohazard3737 I mean honestly at this point If I were you I'd be willing to explore legal options. Obviously retail can't do that. But dropping this crap after french workhours ended and on opex day and literally saying "we are willing to cover our short after that" should be illegal
@countdraghula I mean yeah,but aren't we just pricing AI slowdown? Employment fine, inflation high and all that
(Fwiw i think we might get a recession late next year or 28 if AI debt blows up in Q2-Q3 27, which I think is very real possibility, but we're not there yet)
@beniduboss You're looking at wrong things mate. Try to look top down at debt and revenue. We aren't getting anywhere close to enough revenue to make datacenters buildout profitable (well maybe we do, but it ain't happening next year or even in 28)
@BobEUnlimited The productivity gain that I hear from my friends so far is mostly that they work less. Which is actually real productivity, but it won't show up in daya for a long time
@deathtouch2k I'm not a biologist myself,but my company works on capsids and promoter and serotypes for gene therapy. Like everything they need to be characterized and tested in a lab and in animals to see if they actually do what they are supposed to be doing
@kevin__mak Oh NVDA will be fine for sure. I'm talking about private credit debt that is collateralized by GPUs. If margins drop that means prices drop for new GPUs, which means prices drop even more for old GPUs
And again you need 1T revenue next year, not in 2030. Not gonna happen
@kevin__mak That's closer to reality. AI will be transformative.Timing is the issue.
Next questions:
1) what happens to ANT&OAI valuation if their margins compress to 35%? It has to happen BEFORE they get their revenue
2) what happens to debt collateralized by GPUs if NVDA margins compress??
@citrini Im in drug devt and I'm working on TPPs for a few projects.Reduced time to create TPP from a few weeks of work with a team of consultants to a few days with two people
Results isnt perfect and requires a lot of cleaning by people with actual knowledge,but its very good as a blank
@mickeychiku I have a strange feeling being big long QURE. I kinda want them to be approved because of that. But at the same time I don't want them to be approved because it's just bad policy which is bad for market long term
@A_May_MD Best part is its like they have a completely different investor base.RYTM fell 5% yesterday with the market even after WSJ article.Its easy to explain - people need margin and rotate
SYRE investors are from another planet,they just came out of nowhere and bought and they HODL
@countdraghula Well if Mike Green is correct in his estimations than it's the only thing that matters.
And that also explains that index is barely moving while there is absolute bloodbath under the hood. I'm in biotech and it's way worser than 21-22 and 25 and I believe tech is close to that